Anticancer gets chemotherapy assessment patent:
This article was originally published in Clinica
Executive Summary
San Diego-based Anticancer has received a US patent for its chemotherapy assessment assay. The test uses biopsy material to assess a tumour's susceptibility to a variety of therapeutic agents.